Chondroneutrality of meloxicam in rats with spontaneous osteoarthrosis of the ankle joint

Zeitschrift fur Rheumatologie

Volumn 56, Issue 1, 1997, Pages 21-30

  Mohr, W ^a   Lehmann, H ^b   Engelhardt, G ^b  

^a UNIVERSITY OF ULM   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

histology; meloxicam; non steroidal anti inflammatory drug; osteoarthrosis of ankle joints; rats

Indexed keywords

MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANKLE; ARTICLE; CARTILAGE; CONTROLLED STUDY; HISTOPATHOLOGY; NONHUMAN; OSTEOARTHRITIS; RAT;

ANIMALS; ANKLE JOINT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARTILAGE, ARTICULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LONG-TERM CARE; MALE; OSTEOARTHRITIS; RATS; RATS, SPRAGUE-DAWLEY; THIAZINES; THIAZOLES;

EID: 0030977129     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003930050017     Document Type: Article

References (68)

1. Alspaugh MA, van Hoosier GL (1973) Naturally-occurring and experimentally-induced arthritides in rodents: A review of the literature. Lab Anim Sci 23:723-742
2. Arora JS, Mandsley RH (1968) Indocid arthropathy of hips. Proc R Soc Med 61:669
3. Bassleer C, Franchimont P (1995) Effects of meloxicam compared to acetylsalicylic acid in human articular chondrocytes. Rheumatology in Europe 24:(Suppl 3)324
4. Bassleer CT, Henrotin YE, Franchimont PP (1993) Effects of ximoprofen and acetylsalicylic acid on human articular chondrocytes in 3-dimensional culture. Drug Invest 5:11-18
5. Bassleer CT, Henrotin YE, Reginster JYL, Franchimont PP (1992) Effects of tiaprofenic acid and acetylsalicylic acid on human articular chondrocytes in 3-dimensional culture. J Rheumatol 19:1433-1438
6. Bendele AM, Hulman JF (1988) Spontaneous cartilage degeneration in guinea pigs. Arthritis Rheum 31: 561-565
7. Bjelle A, Eronen I (1991) The in vitro effect of six NSAIDs on the glycosaminoglycan metabolism of rabbit chondrocytes. Clin Exper Rheumatol 9:369-374
8. Brandt KD (1987) Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo. Am J Med 83:(Suppl 5A) 29-34
9. Brandt KD, Albrecht ME, Kalasinski LA (1990) Effects of tiaprofenic acid on the concentration and metabolism of proteoglycans in normal and degenerating canine articular cartilage. J Clin Pharmacol 30:808-814
10. Busch U (1994) The pharmacokinetics of meloxicam in animals. Scand J Rheumatol, Suppl 98:A119
11. Busch U, Schmid J (1987) Pharmacokinetic properties of meloxicam, a new NSAID, in different species. Clin Exp Rheumatol 5:(Suppl 2)145
12. Churchill L, Graham AG, Shih C-K, Pauletti D, Farina PR, Grob PM (1996) Selective inhibition of human cyclooxygenase-2 by meloxicam. Inflammopharmacology 4:125-135
13. Coke H (1967) Long term indomethacin therapy for coxarthrosis. Ann Rheum Dis 26:346-347
14. Collier S, Ghosh P (1991) Comparison of the effects of non-steroidal anti-inflammatory drugs (NSAIDs) on proteoglycan synthesis by articular cartilage expiant and chondrocyte monolayer cultures. Biochem Pharmacol 41: 1375-1384
15. Colombo C, Butler M, Hickman L, Selwyn M, Chart J, Steinetz B (1983) A new model of osteoarthritis in rabbits. Arthritis Rheum 26:1132-1139
16. Davies MA, Ettinger WH, Neuhans JM (1990) Obesity and osteoarthritis of the knee: Evidence from the National Health and Nutrition Examination Survey. Semin Arthritis Rheum 20:(Suppl 3/1)34-41
17. Dingle JT (1991) Cartilage maintenance in osteoarthritis: Interaction of cytokines, NSAID and prostaglandins in articular cartilage damage and repair. J Rheumatol 18:(Suppl 28) 30-37
18. Distel M, Mueller C, Bluhmki E, Fries J (1996) Safety of meloxicam, a global analysis of clinical trials. Br J Rheumatol 35:(Suppl 6)68-77
19. Doherty M, Holt M, MacMillan P, Watt J, Dieppe P (1986) A reappraisal of "analgesic hip". Ann Rheum Dis 45:272-276
20. Emery P (1996) Clinical implications of selective cyclooxygenase-2 inhibition. Scand J Rheum 25:(Suppl 102)23-28
21. Engelhardt G (1994) Meloxicam inhibits preferentially COX-2. Eur J Clin Pharmacol 47:A98
22. Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C (1995) Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm Res 44:423-433
23. Engelhardt G, Homma D, Schnitzler C (1995) Meloxicam: A potent inhibitor of adjuvant arthritis in the Lewis rat. Inflamm Res 44:548-555
24. Engelhardt G (1996) Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2. Br J Rheumatol 25:(Suppl 1)4-12
25. Engelhardt G, Bögel R, Schnitzler Chr, Utzmann R (1996) Meloxicam: Influence on arachidonic acid metabolism. In vitro findings - Part I. Biochem Pharmacol 51:21-28
26. Engelhardt G, Bögel R, Schnitzler Chr, Utzmann R (1996) Meloxicam: Influence on arachidonic acid metabolism. In vivo findings - Part 2. Biochem Pharmacol 51:29-38
27. Felson DT, Radin EL (1994) What causes knee osteoarthrosis: Are different compartements susceptible to different risk factors? J Rheumatol 21:181-183
28. Fernandes JC, Martel-Pelletier J, Otterness IG, Lopez-Anaya A, Mineau F, Tardif G, Pelletier JP (1995) Effects of tenidap on canine experimental osteoarthritis. I. Morphologic and metalloprotease analysis. Arthritis Rheum 38:1290-1303
29. Ghosh P, Wells C, Numata Y, Read R, Armstrong S (1993) The effects of orally administered tiaprofenic acid on the biosynthesis of proteoglycans in ex vivo cartilage cultures from joints of animals with early osteoarthritis. Curr Therap Res 54:703-713
30. Gishen P, Jubb R, Doyle DV (1995) Indomethacin increases the risk of radiological deterioration in osteoarthritis of the knee: Tiaprofenic acid does not. Rheumatology in Europe 24:(Suppl 3)331
31. Herman JE, Appel AM, Khosla RC, Hess EV (1986) In vitro effect of select classes of nonsteroidal antiinflammatory drugs on normal cartilage metabolism. J Rheumatol 13: 1014-1018
32. Howell DS, Pita JC, Muller FJ, Manicourt DH, Altman RD (1991) Treatment of osteoarthritis with tiaprofenic acid: Biochemical and histological protection against cartilage breakdown in the Pond-Nuki canine model. J Rheumatol 18:(Suppl 27) 138-142
33. Kalbhen DA (1987) Chemical model of osteoarthritis - a pharmacological evaluation. J Rheumatol 14:(Suppl 14)130-131
34. Kalbhen DA, Schauer M, Wentsche B (1978) Tierexperimentelle Untersuchungen über den Einfluß intraartikulär applizierter Antiphlogistika/Antirheumatika auf den Gelenkknorpel in vivo. Z Rheumatol 37:380-394
35. Kohatsu ND, Schurman DJ (1990) Risk factors for the development of osteoarthrosis of the knee. Clin Orthop 216:242-246
36. Lehmann H, Baumeister M, Lützen L, Wiegleb J (1995) Meloxicam: A toxicological overview. Inflammopharmacol 4:105-123
37. Maier R, Wilhelmi G (1983) Evaluierung der Wirkung von Analgetika/Antiphlogistika auf die Progredienz der Spontanarthrose der C57-black-Maus. (Evaluation of the effect of analgesics/ anti-inflammatories on the progression of spontaneous osteoarthritis in the C57 black mouse). Z Rheumatol 42:232-234
38. Maier R, Wilhelmi G (1984) Preclinical investigations of drug effects in models of osteoarthrosis. In: Munthe E, Bjelle A (eds) Effects of drugs on osteoarthrosis. Proceedings of the 10th European Congress of Rheumatology, Moscow, 1983. Berne, Hans Huber, pp 90-96
39. McKenzie LS, Horsburgh BA, Ghosh P, Taylor TKF (1976) Effect of anti-inflammatory drugs on sulphated glycosaminoglycan synthesis in aged human articular cartilage. Ann Rheum Dis 35:487-496
40. Meyer-Carrive I, Ghosh P (1992) Effects of tiaprofenic acid (Surgam) on cartilage proteoglycans in the rabbit joint immobilisation model. Ann Rheum Dis 51:448-455
41. Meyer-Carrive I, Graham GG, Ghosh P (1993) Pharmacokinetics of tiaprofenic acid in normal rabbits and rabbits subjected to joint immobilisation. Agents Actions 39:59-68
42. Milner JC (1973) Osteoarthritis of the hip and indomethacin. J Bone Joint Surg 54B:752
43. Mohr W, Lehmann H (1992) Osteoarthrosis of the ankle joint in old rats. Z Rheumatol 51:35-40
44. Palmoski MJ, Brandt KD (1979) Effect of salicylate on proteoglycan metabolism in normal canine articular cartilage in vitro. Arthritis Rheum 22: 746-754
45. Palmoski MJ, Brandt KD (1980) Effects of some nonsteroidal antiinflammatory drugs on proteoglycan metabolism and organization in canine articular cartilage. Arthritis Rheum 23:1010-1020
46. Palmoski MJ, Brandt KD (1983) In vivo effect of aspirin on canine osteoarthritic cartilage. Arthritis Rheum 26: 994-1001
47. 2 synthesis in intact canine knee cartilage ex vivo. Arthritis Rheum 27: 398-403
48. Palmoski MJ, Brandt KD (1985) Proteoglycan depletion, rather than fibrillation, determines the effects of salicylate and indomethacin on osteoarthritic cartilage. Arthritis Rheum 28:548-553
49. Palmoski MJ, Colyer RA, Brandt KD (1980) Marked suppression by salicylate of the augmented proteoglycan synthesis in osteoarthritic cartilage. Arthritis Rheum 23:83-91
50. Pelletier JP, Cloutier JM, Martel-Pelletier J (1989) In vitro effects of tiaprofenic acid, sodium salicylate and hydrocortisone on the proteoglycan metabolism of human osteoarthritic cartilage. J Rheumatol 16:646-655
51. Pelletier JP, Haraoni B, Martel-Pelletier J (1993) Modulation of cartilage degradation in arthritic diseases by therapeutic agents. In: Woessner JF Jr, Howell DS (eds) Joint cartilage degradation. Marcel Dekker, New York Basel Hong Kong, pp 503-528
52. Pelletier JP, Martel-Pelletier J (1991) In vivo protective effects of prophylactic treatment with tiaprofenic acid or intraarticular corticosteroids on osteoarthritic lesions in the experimental dog model. J Rheumatol 18:(Suppl 27) 127-130
53. Pelletier JP, McCollum R, Cloutier JM, Martel-Pelletier J (1992) Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium. Brit J Rheumatol 31:(Suppl 1)19-26
54. Rainsford KD (1994) Inhibition of cartilage proteoglycan synthesis by NSAIDs and its relationship to long-term joint damage in OA. Scand J Rheumatol 98:(Suppl)138
55. Rainsford KD, Ying C, Smith F (1994) Comparative effects of meloxicam on cartilage-synovial components of joint injury in vitro. 2nd Intern Congr of the Osteoarthritis Research Society, Orlando, Florida, 9-11 Dec
56. Ratcliffe A, Azzo W, Saed-Nejad F, Lane N, Rosenwasser MP, Mow VC (1993) In vivo effects of naproxen on composition, proteoglycan metabolism, and matrix metalloproteinase activities in canine articular cartilage. J Orthop Res 11:163-171
57. Ratcliffe P, Glaser P, Azzo W, Saed-Nejad VC (1990) Naproxen reduces proteoglycan turnover and metalloproteinase activity in normal and IL 1-treated articular cartilage. Arthritis Rheum 33:(Suppl)591
58. Rønningen H, Langeland N (1979) Indomethacin treatment in osteoarthritis of the hip joint. Does the treatment interfere with the natural course of the disease? Acta Orthop Scand 50: 169-174
59. Rosenberg L (1971) Chemical basis for the histological use of safranin O in the study of articular cartilage. J Bone Joint Surg [Am] 53:69-82
60. Schmid J, Busch U, Heinzel G, Bozler G, Kaschke S, Kummer M (1995) Meloxicam: Pharmaco-kinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects. Drug Metab Dispos 23:1206-1213
61. Shield MJ (1993) Anit-inflammatory drugs and their effects on cartilage synthesis and renal function. Europ J Rheumatol Inflamm 13:7-16
62. Snedecor GW, Cochran WG (1968) Statistical methods (6th edition), Iowa State University Press, Ames, Iowa, USA, pp 238-239
63. Sokoloff L, Jay GE Jr (1956) Natural history of degenerative joint disease in small laboratory animals. IV. Degenerative joint disease in the laboratory rat. Arch Pathol 62:140-142
64. Türck D, Roth W, Busch U (1996) A review of the clinical pharmacokinetics of meloxicam. Br J Rheumatol 25 (Suppl 1):13-16
65. Vignon E, Mathieu P, Broquet P, Louisot P, Richard M (1990) Cartilage degradation enzymes in human osteoarthritis: Effect of a nonsteroidal antiinflammatory drug administered orally. Semin Arthritis Rheum 19 (Suppl 1):26-29
66. Wilhelmi G (1978) Effect of C21, 524-SU (pirprofen) on spontaneous osteoarthritis in the mouse. Pharmacology 16:268-272
67. Wilhelmi G (1978) Fördernde und hemmende Einflüsse von Tribenosid und Acetylsalicylsäure auf die spontane Arthrose der Maus. Arzneimittelforschung 28:1724-1726
68. Will RK, Barnes J, Caspersz C, Hall N, Maddison P (1992) Proteoglycan synthesis is induced by azapropazone and inhibited by indomethacin in patients with osteoarthritis of the knee. Brit J Rheumatol 31 (Suppl 2):201